Spatial Analysis of Global Variability in Covid-19 Burden
BACKGROUND: Since the first occurrence of coronavirus disease 2019 (Covid-19), a number of online tools have become available to assist with tracking Covid-19 prevalence. Yet we are unaware of resources that provide country-specific Covid-19 incidence data. METHODS: We undertook a descriptive analys...
Published in: | Risk Management and Healthcare Policy |
---|---|
Main Authors: | , , |
Format: | Text |
Language: | English |
Published: |
Dove
2020
|
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280244/ http://www.ncbi.nlm.nih.gov/pubmed/32581614 https://doi.org/10.2147/RMHP.S255793 |
id |
ftpubmed:oai:pubmedcentral.nih.gov:7280244 |
---|---|
record_format |
openpolar |
spelling |
ftpubmed:oai:pubmedcentral.nih.gov:7280244 2023-05-15T16:51:08+02:00 Spatial Analysis of Global Variability in Covid-19 Burden Miller, Larry E Bhattacharyya, Ruemon Miller, Anna L 2020-06-04 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280244/ http://www.ncbi.nlm.nih.gov/pubmed/32581614 https://doi.org/10.2147/RMHP.S255793 en eng Dove http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280244/ http://www.ncbi.nlm.nih.gov/pubmed/32581614 http://dx.doi.org/10.2147/RMHP.S255793 © 2020 Miller et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). CC-BY-NC Risk Manag Healthc Policy Rapid Communication Text 2020 ftpubmed https://doi.org/10.2147/RMHP.S255793 2020-06-28T00:15:15Z BACKGROUND: Since the first occurrence of coronavirus disease 2019 (Covid-19), a number of online tools have become available to assist with tracking Covid-19 prevalence. Yet we are unaware of resources that provide country-specific Covid-19 incidence data. METHODS: We undertook a descriptive analysis of the global impact of Covid-19 using data reported on March 17, 2020. The prevalence of Covid-19 cases, fatalities attributed to Covid-19, and the case fatality rate for each of the 238 countries were accessed from the World Health Organization global Covid-19 tracking site, and we additionally calculated Covid-19 incidence based on country-specific population data. We determined the country-specific point prevalence and incidence of Covid-19 and associated deaths while using geocoded data to display their spatial distribution with geographic heat maps. RESULTS: The analysis included 193,197 Covid-19 cases and 7859 associated deaths. The point prevalence was highest in China (80,881), Italy (31,506), Iran (16,169), and Spain (11,312); no other country reported more than 10,000 cases. The incidence (per million population) was highest in San Marino (3389) followed by Iceland (645) and Italy (521); no other country had an incidence above 400 per million population. CONCLUSION: Countries with a high Covid-19 prevalence may not have a high incidence, and vice versa. Public health agencies that provide real-time infection tracking tools should report country-specific Covid-19 incidence metrics, in addition to prevalence data. Text Iceland PubMed Central (PMC) Risk Management and Healthcare Policy Volume 13 519 522 |
institution |
Open Polar |
collection |
PubMed Central (PMC) |
op_collection_id |
ftpubmed |
language |
English |
topic |
Rapid Communication |
spellingShingle |
Rapid Communication Miller, Larry E Bhattacharyya, Ruemon Miller, Anna L Spatial Analysis of Global Variability in Covid-19 Burden |
topic_facet |
Rapid Communication |
description |
BACKGROUND: Since the first occurrence of coronavirus disease 2019 (Covid-19), a number of online tools have become available to assist with tracking Covid-19 prevalence. Yet we are unaware of resources that provide country-specific Covid-19 incidence data. METHODS: We undertook a descriptive analysis of the global impact of Covid-19 using data reported on March 17, 2020. The prevalence of Covid-19 cases, fatalities attributed to Covid-19, and the case fatality rate for each of the 238 countries were accessed from the World Health Organization global Covid-19 tracking site, and we additionally calculated Covid-19 incidence based on country-specific population data. We determined the country-specific point prevalence and incidence of Covid-19 and associated deaths while using geocoded data to display their spatial distribution with geographic heat maps. RESULTS: The analysis included 193,197 Covid-19 cases and 7859 associated deaths. The point prevalence was highest in China (80,881), Italy (31,506), Iran (16,169), and Spain (11,312); no other country reported more than 10,000 cases. The incidence (per million population) was highest in San Marino (3389) followed by Iceland (645) and Italy (521); no other country had an incidence above 400 per million population. CONCLUSION: Countries with a high Covid-19 prevalence may not have a high incidence, and vice versa. Public health agencies that provide real-time infection tracking tools should report country-specific Covid-19 incidence metrics, in addition to prevalence data. |
format |
Text |
author |
Miller, Larry E Bhattacharyya, Ruemon Miller, Anna L |
author_facet |
Miller, Larry E Bhattacharyya, Ruemon Miller, Anna L |
author_sort |
Miller, Larry E |
title |
Spatial Analysis of Global Variability in Covid-19 Burden |
title_short |
Spatial Analysis of Global Variability in Covid-19 Burden |
title_full |
Spatial Analysis of Global Variability in Covid-19 Burden |
title_fullStr |
Spatial Analysis of Global Variability in Covid-19 Burden |
title_full_unstemmed |
Spatial Analysis of Global Variability in Covid-19 Burden |
title_sort |
spatial analysis of global variability in covid-19 burden |
publisher |
Dove |
publishDate |
2020 |
url |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280244/ http://www.ncbi.nlm.nih.gov/pubmed/32581614 https://doi.org/10.2147/RMHP.S255793 |
genre |
Iceland |
genre_facet |
Iceland |
op_source |
Risk Manag Healthc Policy |
op_relation |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280244/ http://www.ncbi.nlm.nih.gov/pubmed/32581614 http://dx.doi.org/10.2147/RMHP.S255793 |
op_rights |
© 2020 Miller et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
op_rightsnorm |
CC-BY-NC |
op_doi |
https://doi.org/10.2147/RMHP.S255793 |
container_title |
Risk Management and Healthcare Policy |
container_volume |
Volume 13 |
container_start_page |
519 |
op_container_end_page |
522 |
_version_ |
1766041248795197440 |